BA
DMTX

BlackRock Advisors’s Dimension Therapeutics, Inc DMTX Stock Holding History

BlackRock Advisors’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23K Buy
5,357
+672
+14% +$3.58K ﹤0.01% 3435
2016
Q3 		$37K Buy
4,685
+1,393
+42% +$10.1K ﹤0.01% 3333
2016
Q2 		$20K Buy
3,292
+1,545
+88% +$11.8K ﹤0.01% 3454
2016
Q1 		$14K Hold
1,747
– – ﹤0.01% 3523
2015
Q4 		$20K Buy
+1,747
New +$22.1K ﹤0.01% 3498

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

BlackRock Advisors's DMTX Position: Q4 2016 in Review

BlackRock Advisors increased its Dimension Therapeutics, Inc (DMTX) stake by 14% in Q4 2016, buying an estimated $3.58K and bringing the position to 5,357 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3435.

BlackRock Advisors first reported a position in DMTX in Q4 2015 and has held it in 5 quarters since. The position peaked at $37K in Q3 2016. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

  • BlackRock Advisors held 5,357 shares of Dimension Therapeutics, Inc worth $23K as of Q4 2016.
  • BlackRock Advisors bought 672 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $3.58K.
  • Dimension Therapeutics, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3435 holding.
  • BlackRock Advisors first reported a position in Dimension Therapeutics, Inc in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Dimension Therapeutics, Inc position peaked at $37K in Q3 2016.
  • 55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.